Morrow, K, Costello, T.
HIV, STD and hepatitis prevention among women in methadone maintenance: a qualitative and quantitative needs assessment. AIDS Care
2004; 16: 426–33.
Walley, AY, White, MC, Kushel, MB, Song, YS, Tulsky, JP. Knowledge of and interest in hepatitis C treatment at a methadone clinic. J Subst Abuse Treat
2005; 28: 182–7.
Faggiano, F, Vigna-Taglianti, F, Versino, E, Lemma, P.
Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev
2003; 3: CD002208.
Mattick, RP, Kimber, J, Breen, C, Davoli, M.
Buprenorphine vs placebo or methadone for opioid dependence. Cochrane Database Syst Rev
2008; 2: CD002207.
Darke, S, Ross, J, Teesson, M.
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat
2005; 28: 255–63.
Gossop, M, Marsden, J, Stewart, D, Kidd, T.
National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction
2003; 98: 291–303.
Ward, J, Mattick, RP, Hall, W.
Methadone Maintenance Treatment & Opioid Replacement Therapies. Harwood Academic, 1998.
Bell, J, Burrell, T, Indig, D, Gilmour, S.
Cycling in and out of treatment: participation in methadone treatment in NSW, 1990-2002. Drug Alcohol Depend
2006; 81: 55–61.
Treloar, C, Abelson, J, Cao, W, Brener, L, Kippax, S, Schultz, L, et al. Barriers and Incentives to Treatment for Illicit Drug Users (Monograph 53). Australian Government Department of Health & Ageing, National Drug Strategy, 2004.
Fischer, B, Chin, AT, Kuo, I, Kirst, M, Vlahov, D.
Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse
2002; 37: 495–522.
Schwartz, RP, Kelly, SM, O'Grady, KE, Mitchell, SG, Peterson, JA, Reisinger, HS, et al. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict
2008; 17: 396–401.
Madden, A, Lea, T, Bath, N, Winstock, AR. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Drug Alcohol Rev
2008; 27: 671–8.
Pinto, H, Rumball, D, Holland, R.
Attitudes and knowledge of substance misusers regarding buprenorphine and methadone maintenance therapy. J Subst Use
2008; 13: 143–53.
Winstock, AR, Lea, T, Maden, A, Bath, N.
Knowledge about buprenorphine and methadone among those receiving treatment for opioid dependence. Drugs Educ Prev Pol
2008; 15: 395–409.
Brown, CS, Wright, RG, Christensen, DB. Association between type of medication instruction and patients' knowledge, side effects and compliance. Hosp Community Psychiatry
1987; 38: 55–60.
Haw, C, Stubbs, J, Calton, R, Haynes, H.
Long-stay psychiatric patients' knowledge and experience in the use of their antipsychotic medication. Hospital Pharmacist
2001; 8: 166–72.
Crossley, R, Withers, P.
Antipsychotic medication and people with intellectual disabilities: their knowledge and experiences. J Appl Res Intellect Disabil
2009; 22: 77–86.
McLellan, AT, Lewis, DC, O'Brien, CP, Kleber, HD. Drug dependence, a chronic medical illness: implications for treatment, insurance and outcomes evaluation. JAMA
2000; 283: 1689–95.
Hill, J, Bird, H, Johnson, S.
Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis
2001; 60: 869–75.
Winstock, AR, Lea, T, Fettell, A.
Pilot evaluation of an educational DVD for people with opioid dependence. Drugs Educ Prev Pol
2009; 16: 182–92.
Winstock, A, Lea, T, Maiden, A, Bath, N.
Knowledge about buprenorphine and methadone among those receiving treatment for opiate dependence. Drugs Educ Prev Pol
2008; 15: 395–409.
Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens. J Adv Nurs
1996; 24: 244–50.
Chapman, KR, Walker, L, Cluley, S, Fabbri, L.
Improving patient compliance with asthma therapy. Respir Med
2000; 94: 2–9.
Cochrane, GM, Horne, R, Chanez, P.
Compliance in asthma. Respir Med
1999; 93: 763–9.
Lutfey, KE, Wishner, WJ. Beyond compliance is adherence. Improving the prospect of diabetes care. Diabetes Care
1999; 22: 635–9.
Zaller, ND, Bazazi, AR, Velazquez, L, Rich, L.
Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int J Environ Res Public Health
2009; 6: 787–97.
Zanis, DA, Woody, GE. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend
1998; 52: 257–60.
Dietze, P, Jolley, D, Fry, CL, Bammer, G, Moore, D.
When is little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug Alcohol Depend
2006; 84: 223–30.
Worthington, N, Piper, TM, Galea, S, Rosenthal, D.
Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study. Harm Reduct J
2006; 3: 19.
Strang, J, Manning, V, Mayet, S, Best, D, Titherington, E, Santana, L, et al. Overdose training and take-home naloxone for opiate users: a prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction
2008; 163: 1648–57.
White, DC, Schelten, SL, Kelly, BD, Casey, P.
Written information on bipolar affective disorder: the patients' perspective. Psychiatrist
2010; 34: 418–22.
Andrews, S, Sorensen, JL, Guydish, JR, Delucchi, K, Greenberg, B.
Knowledge and attitudes about methadone maintenance among staff working in a therapeutic community. J Maint Addict
2005; 3: 47–59.
Knudsen, HK, Ducharme, LJ, Roman, PM. Research network involvement and addiction treatment center staff: counsellor attitudes toward buprenorphine. Am J Addict
2007; 16: 365–371.
Davis, TC, Jackson, RH, George, RB, Long, SW, Talley, D, Murphy, PW, et al. Reading ability in patients in substance misuse treatment centers. Int J Addict
1993; 28: 571–82.
Sokya, M, Zingg, C, Koller, G, Kuefner, H.
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study. Int J Neuropsychopharmacol
2008; 11: 641–53.
Stancliff, S, Myers, JE, Steiner, S, Drucker, E.
Beliefs about methadone in an inner-city methadone clinic. J Urban Health
2002; 79: 571–8.